{"entity":{"type":"insider","cik":"0001739816","url":"/insider/0001739816","json_url":"/insider/0001739816.json","name":"Boyd Peter E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2018-11-26","last":"2026-03-11","span_basis":"filed_date"},"name_variants":[{"name":"Boyd Peter E.","source":"filing","n_filings":9,"first_seen":"2018-11-26","last_seen":"2026-03-11"}],"transactions":[{"id":5873917,"accession":"0001214659-26-003147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-26-003147","line_url":"/filing/0001214659-26-003147#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer (Chief People Officer)","role_mark":"O","role_mark_label":"Officer (Chief People Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief People Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29814.0,"shares_display":"29,814","price_per_share":4.173,"price_display":"4.17","price_state":"stated","total_value":124413.822,"total_display":"124,413.82","total_whole":"124,414","shares_owned_after":338509.0,"shares_owned_after_display":"338,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":4136664,"accession":"0001214659-25-015046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-015046","line_url":"/filing/0001214659-25-015046#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":70000.0,"total_display":"70,000.00","total_whole":"70,000","shares_owned_after":268323.0,"shares_owned_after_display":"268,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-17","scope":"insider"},{"id":4492212,"accession":"0001214659-25-014287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-014287","line_url":"/filing/0001214659-25-014287#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":63000.0,"total_display":"63,000.00","total_whole":"63,000","shares_owned_after":278323.0,"shares_owned_after_display":"278,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-29","scope":"insider"},{"id":5144409,"accession":"0001214659-25-013485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-013485","line_url":"/filing/0001214659-25-013485#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":79500.0,"total_display":"79,500.00","total_whole":"79,500","shares_owned_after":288323.0,"shares_owned_after_display":"288,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":6461146,"accession":"0001628280-22-017186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-017186","line_url":"/filing/0001628280-22-017186#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer (SVP-Bus. Process & Info. Tech)","role_mark":"O","role_mark_label":"Officer (SVP-Bus. Process & Info. Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Bus. Process & Info. Tech.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":4050.0,"total_display":"4,050.00","total_whole":"4,050","shares_owned_after":59532.0,"shares_owned_after_display":"59,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-15","scope":"insider"},{"id":6103453,"accession":"0001628280-22-016872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-016872","line_url":"/filing/0001628280-22-016872#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer (SVP-Bus. Process & Info. Tech)","role_mark":"O","role_mark_label":"Officer (SVP-Bus. Process & Info. Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Bus. Process & Info. Tech.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2293.0,"shares_display":"2,293","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":2201.28,"total_display":"2,201.28","total_whole":"2,201","shares_owned_after":54532.0,"shares_owned_after_display":"54,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":2480858,"accession":"0001214659-20-002746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-20-002746","line_url":"/filing/0001214659-20-002746#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer (SVP-Bus. Process & Info. Tech)","role_mark":"O","role_mark_label":"Officer (SVP-Bus. Process & Info. Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Bus. Process & Info. Tech.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":52239.0,"shares_owned_after_display":"52,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":8033035,"accession":"0001214659-19-005182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-19-005182","line_url":"/filing/0001214659-19-005182#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer (SVP-Bus. Process & Info. Tech)","role_mark":"O","role_mark_label":"Officer (SVP-Bus. Process & Info. Tech)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Bus. Process & Info. Tech.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":2286.0,"total_display":"2,286.00","total_whole":"2,286","shares_owned_after":50239.0,"shares_owned_after_display":"50,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-13","scope":"insider"},{"id":6654469,"accession":"0001140361-18-043649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-043649","line_url":"/filing/0001140361-18-043649#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001739816","owner_name":"Boyd Peter E.","owner_display_name":"Boyd Peter E.","owner_url":"/insider/0001739816","role":"Officer (SVP-Operations/Value Delivery)","role_mark":"O","role_mark_label":"Officer (SVP-Operations/Value Delivery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Operations/Value Delivery","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":9.98,"price_display":"9.98","price_state":"stated","total_value":1996.0,"total_display":"1,996.00","total_whole":"1,996","shares_owned_after":49639.0,"shares_owned_after_display":"49,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-21","filed_date":"2018-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Officer (Chief People Officer)","n_filings":9,"first_seen":"2018-11-26","last_seen":"2026-03-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001739816","retrieved_at":"2026-08-25T09:12:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}